Brain Metastases from Ewing's Sarcoma

2009 ◽  
Vol 22 (4) ◽  
pp. 443-447 ◽  
Author(s):  
M. Bekiesinska-Figatowska ◽  
E. Jurkiewicz ◽  
A. Raciborska

Ewing's sarcoma accounts for approximately 30% of primary malignant bone tumors, mainly in children and young adults. At the time of diagnosis many patients already have metastatic spread of the disease, most often to the lungs and skeletal system. Intracerebral metastases are rare — the reported incidence is up to 4.3%. We describe two cases of metastatic deposits within the brain tissue. Signal intensity of the lesions was similar to that of meningioma on all sequences. Strong homogenous enhancement after gadolinium administration was also similar to meningioma.

2013 ◽  
Vol 37 (4) ◽  
pp. 181-191 ◽  
Author(s):  
Kuntal A. Rana ◽  
John Meyer ◽  
Saman Ibrahim ◽  
Michael Ralls ◽  
Paul M. Kent

Neurosurgery ◽  
1984 ◽  
Vol 15 (6) ◽  
pp. 873-877 ◽  
Author(s):  
Steven L. Wald ◽  
Thomas A. Roland

Abstract Ewing's sarcoma is a rare primary osseous neoplasm of children and young adults. The use of radiotherapy and adjuvant chemotherapy has favorably influenced the outcome of patients and dramatically reduced the rate of local disease recurrence. However, distant metastasis, usually to the lung and skeletal system, continues to be a frequent preterminal event. Metastasis to the central nervous system is infrequent unless related to adjacent bone involvement. We report a case of intraneural, intradural metastasis in a young man with a previously treated Ewing's sarcoma of the ilium. Metastasis to this part of the nervous system has not been previously reported.


Sarcoma ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Joshua D. Schiffman ◽  
Jennifer Wright

Ewing's sarcoma (ES) is a rare tumor that is most common in children and young adults. Late effects of ES therapy include second cancers, a tragic outcome for survivors of such a young age. This paper will explore the frequencies and types of malignancies that occur after ES. Additionally, it will review how second malignancies have changed with the shift in treatment from high-dose radiation to chemotherapy regimens including alkylators and epipodophyllotoxins. The risk of additional cancers in ES survivors will also be compared to survivors of other childhood cancers. Finally, the possible genetic contribution to ES and second malignancies will be discussed.


2016 ◽  
Vol 64 (3) ◽  
pp. 403
Author(s):  
Gisela Barros ◽  
Angela Maria Trujillo ◽  
Lina Jaramillo ◽  
Francy Helena Ortiz ◽  
Agustin Dario Contreras

Background: Osteosarcoma (OS) and Ewing’s Sarcoma (ES) are the two most common malignant bone tumors in children. A retrospective review of the records of children diagnosed in a pediatric hospital over a five year period (2008-2013) was performed.Objective: To present the experiences acquired during the treatment of these types of tumors and to compare the results obtained with those reported in the literature.Methodology: The database of the Oncology and Pathology Service of Fundación Hospital de la Misericordia (HOMI) was reviewed to identify patients with primary bone tumors referred for histopathology analysis.Results: 22 patients were diagnosed with OS, with a mean age of 11.9 years. 96% of cases were located in the lower extremities. All patients received neoadjuvant chemotherapy and 86% underwent surgical treatment; 13% survived. 15 patients were diagnosed with ES, with a mean age of 12.4 years. 67% of cases were located in flat bones, 53% of patients had metastasis when diagnosed, and all received neoadjuvant chemotherapy. 40% of patients received surgical intervention and 20% received radiotherapy. Survival at the completion of the reseearch was 33%.Conclusions: Cure and survival rates are lower than those reported in the literature despite efforts to improve treatments.Keywords: Osteosarcoma; Ewing’s Sarcoma; Disease Progression; Recurrence; Neoplasm Metastasis (MeSH).


2008 ◽  
Vol 15 (7) ◽  
pp. 813-817 ◽  
Author(s):  
Aslan Güzel ◽  
Mehmet Tatli ◽  
Uygur Er ◽  
Fahri Yilmaz ◽  
Murad Bavbek

Sign in / Sign up

Export Citation Format

Share Document